Atopic Eczema
27
2
4
17
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 27 trials
100.0%
+13.5% vs benchmark
33%
9 trials in Phase 3/4
12%
2 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (27)
A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis
Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema
Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus
Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies
Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial
Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis
A Community-based Assessment of Skin Care, Allergies, and Eczema
A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic Eczema
A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema
A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema.
A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study
The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover
Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema
Role of Anti-IgE in Severe Childhood Eczema
Evaluation of an Integrated Care Project
Softened Water for Eczema Prevention Pilot Trial
Regulatory T Cells (Tregs) in Polymorphic Light Eruption
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children
Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage